Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide

Prostate Cancer and Prostatic Diseases, Published online: 26 January 2021; doi:10.1038/s41391-020-00309-wAndrogen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide

Source: Prostate Cancer and Prostatic Diseases - January 26, 2021 Category: Urology & Nephrology Authors: M. Del Re V. Conteduca S. Crucitta G. Gurioli C. Casadei G. Restante G. Schepisi C. Lolli F. Cucchiara R. Danesi U. De Giorgi Source Type: research